A Simple Solution Would Make COVID Antivirals More Accessible, Pharmacists Say
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
Can Drugs Reduce the Risk of Long COVID? What Scientists Know So Far
Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms
Messenger RNA Therapies Are Finally Fulfilling Their Promise
Instructing our cells to make specific proteins could control influenza, autoimmune diseases, even cancer
Nasal Spray COVID Preventives Are Finally in Development
Different methods of drug delivery give us more tools to fight disease
Chewing Gum with GMO Could Reduce the Spread of COVID
Gum carrying a protein produced by genetically modified lettuce traps SARS-CoV-2
A Psychedelic May Soon Go to the FDA for Approval to Treat Trauma
MDMA, known as Ecstasy in the clubs, gained high marks in a clinical trial for PTSD
These Are the Latest COVID Treatments
But shortages mean that new antivirals and other drugs may be hard to come by
Preparing for the Next Plague
SARS-CoV-2 adds impetus to the race for broad-spectrum countermeasures against future global infectious scourges
How the New Antiviral Pills Help Thwart COVID
A drug made by Merck and Ridgeback Biotherapeutics—which an FDA panel recently greenlit—and one made by Pfizer work in different ways, but both prevent the virus from replicating
The Weight Game: How Body-Size Bias Can Hold Back Health Science
For decades, assumptions about weight have clouded our view of health
New FDA Chief Will Face COVID Woes and Calls for Drug-Approval Reform
After long delay, U.S. President Joe Biden picks Robert Califf to once again head the U.S. Food and Drug Administration
Investigating Antidepressants’ Surprising Effect on COVID Deaths
Researchers are still puzzling over what this drug does at the molecular level to help COVID patients